BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 26028656)

  • 1. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Lead Failure by Recall Status and Manufacturer: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Schwarzwald SN; Kersten DJ; Shaikh ZA; Needelman BS; Feldman AM; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2018 Apr; 30(4):147-151. PubMed ID: 29610446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Number of Recalled Leads is Highly Predictive of Lead Failure: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Kersten DJ; Yi J; Feldman AM; Brahmbhatt K; Asheld WJ; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2016 Dec; 28(12):E198-E202. PubMed ID: 27922811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-Related and Age-Related Differences in Implantable Defibrillator Recipients: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Feldman AM; Kersten DJ; Chung JA; Asheld WJ; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2015 Dec; 27(12):530-4. PubMed ID: 26630641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Approaches and Outcomes of Defibrillator Lead Implants Between High-Volume and Low-Volume Operators: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Shaikh ZA; Chung JA; Kersten DJ; Feldman AM; Asheld WJ; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2017 Dec; 29(12):E184-E189. PubMed ID: 29207366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
    Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
    Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
    Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
    J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroscopic investigation of Riata® transvenous defibrillator leads.
    Singh G; Lahiri MK; Khan A; Fang KD; Schuger CD
    Cardiol J; 2015; 22(1):57-67. PubMed ID: 24846515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
    Bennett MT; Ha AC; Exner DV; Tung SK; Parkash R; Connors S; Coutu B; Crystal E; Champagne J; Philippon F; Yee R; Stephenson EA; Nery PB; Essebag V; Sanatani S; Redfearn D; Krahn AD; Healey JS
    Heart Rhythm; 2013 Oct; 10(10):1478-81. PubMed ID: 23973950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of the St. Jude Medical Riata defibrillation lead in a large patient population.
    Porterfield JG; Porterfield LM; Kuck KH; Corbisiero R; Greenberg SM; Hindricks G; Wazni O; Beau SL; Herre JM
    J Cardiovasc Electrophysiol; 2010 May; 21(5):551-6. PubMed ID: 19925609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience.
    Sung RK; Massie BM; Varosy PD; Moore H; Rumsfeld J; Lee BK; Keung E
    Heart Rhythm; 2012 Dec; 9(12):1954-61. PubMed ID: 22871583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse Generator Exchange Does Not Accelerate the Rate of Electrical Failure in a Recalled Small Caliber ICD Lead.
    Lovelock JD; Premkumar A; Levy MR; Mengistu A; Hoskins MH; El-Chami MF; Lloyd MS; Leon AR; Langberg JJ; Delurgio DB
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1434-8. PubMed ID: 26285670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.
    Kleemann T; Nonnenmacher F; Strauss M; Kouraki K; Werner N; Fendt A; Zahn R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2012-2019. PubMed ID: 31332876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal follow-up of implantable cardioverter defibrillator leads.
    Liu J; Brumberg G; Rattan R; Patel D; Adelstein E; Jain S; Saba S
    Am J Cardiol; 2014 Jan; 113(1):103-6. PubMed ID: 24176060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
    Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
    Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.